A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice.

Liang Jin,Aihua Zhu,Yu Wang,Qingmei Chen,Qiyan Xiong,Jianping Li,Yunxiao Sun,Taiming Li,Rongyue Cao,Jie Wu,Jingjing Liu
DOI: https://doi.org/10.4049/jimmunol.1090009
2008-01-01
Abstract:Subunit immunogens containing tandemly repeated copies of T and B cell epitopes have been shown to be more immunogenic than the respective immunogen containing only a single copy of the sequence. To investigate whether the increased copies of the Th2-activated peptide sequence will enhance the Th2-like immune response, we compared the cytokine secreted in mice that inoculated with two immunogens containing one or six tandemly repeated copies of a Th2-activated peptide sequence P277. Immunization of mice with a 6xP277 fusion protein elicited much higher levels of Th2-type cytokines and lower Th1-type cytokines than with a fusion protein with one P277 peptide. The data of tandemly repeated peptide P277 potentiate the anti-inflammatory in NOD mice, most likely associated with a Th1 to Th2 cytokine shift specific for the autoimmune T cells, which suggested that application of multiple tandem repeats of a Th2-activated epitope is an efficient method to enhance the anti, immune response by shifting the immune response from Th1-like to Th2-like. The subunit immunogens containing inflammatory tandemly repeated copies of peptide P277 might be effective vaccines against autoimmune diabetes in NOD mice.
What problem does this paper attempt to address?